Showing results (1701-1710 of 1,951) with videos related to
Sort By:
Pageof 196
American Journal of Respiratory and Critical Care Medicine|January 16, 2010
Disease management program for chronic obstructive pulmonary disease: a randomized controlled trialKathryn L Rice, Naresh Dewan, Hanna E Bloomfield, et al.Medical Education|September 19, 2015
The mixed impact of medical school on medical students' implicit and explicit weight biasSean M Phelan, Rebecca M Puhl, Sara E Burke, et al.Pediatric Blood & Cancer|June 18, 2009
Premature carotid artery disease in pediatric cancer survivors treated with neck irradiationKathleen A Meeske, Stuart E Siegel, Vicente Gilsanz, et al.Health Science Reports|June 19, 2023
Quality of life burden on United States infants and caregivers due to lower respiratory tract infection and adjusting for selective testing: Pilot prospective observational studyDhwani Hariharan, V S Senthil Kumar, Elizabeth L Glaser, et al.Plos One|February 8, 2021
SafeNET: Initial development and validation of a real-time tool for predicting mortality risk at the time of hospital transfer to a higher level of careStefanie C Altieri Dunn, Johanna E Bellon, Andrew Bilderback, et al.Frontiers in Human Neuroscience|March 23, 2017
Beta Oscillatory Changes and Retention of Motor Skills during Practice in Healthy Subjects and in Patients with Parkinson's DiseaseAaron B Nelson, Clara Moisello, Jing Lin, et al.Molecular & Cellular Proteomics : MCP|November 10, 2005
Organellar proteomics: analysis of pancreatic zymogen granule membranesXuequn Chen, Angela K Walker, John R Strahler, et al.Journal of Medicinal Chemistry|September 15, 1995
Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activityC F Bigge, T C Malone, P A Boxer, et al.Pharmacology, Biochemistry, and Behavior|February 26, 1998
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonistA E Corbin, T A Pugsley, H C Akunne, et al.The Diabetes Educator|December 17, 2008
Insights and trends in diabetes education: results of the 2008 AADE National Diabetes Education Practice SurveyAnnette Lenzi Martin, Terry Lumber, Terry Compton, et al.Pageof 196